Alnylam Pharmaceuticals vs Tenet Healthcare
Alnylam Pharmaceuticals (ALNY), health care, and Tenet Healthcare (THC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Tenet Healthcare is worth $22.4B on the stock market and Alnylam Pharmaceuticals $21B: Tenet Healthcare is valued at 7% more. Alnylam Pharmaceuticals trades at 7.9 times earnings and Tenet Healthcare at 8.2; operating margins in their latest fiscal years were 13.5% and 16.5%. Over the past year Alnylam Pharmaceuticals's share price has moved -65.4% and Tenet Healthcare's +51.1%.
Key facts
- Alnylam Pharmaceuticals market value
- $21B
- Tenet Healthcare market value
- $22.4B
- Alnylam Pharmaceuticals P/E
- 7.9
- Tenet Healthcare P/E
- 8.2
- Alnylam Pharmaceuticals revenue
- $3.7BFY to 2025-12-31
- Tenet Healthcare revenue
- $21.3BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Alnylam Pharmaceuticals | Tenet Healthcare |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $21Blower | $22.4Bhigher |
| Revenue | $3.7Blower | $21.3Bhigher |
| Earnings | $313.7Mlower | $2.4Bhigher |
| Employees | 2,500lower | 77,000higher |
| Total assets | $5Blower | $29.7Bhigher |
| Valuation | ||
| P/E | 7.9lower | 8.2higher |
| P/S | 5.6higher | 1.1lower |
| P/B | 5.8higher | 4.1lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 13.5%lower | 16.5%higher |
| Balance sheet | ||
| Net assets | $789.2Mlower | $4.2Bhigher |
| Total liabilities | $4.2Blower | $20.7Bhigher |
| Total debt | — | $13.3B |
| Cash on hand | $1.7Blower | $2.9Bhigher |
| Price change | ||
| Today | -2.02%higher | -3.25%lower |
| 1 year | -65.4%lower | +51.1%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Alnylam Pharmaceuticals only (4)
Tenet Healthcare only (3)
- Larry Robbins8.4%
- Ken Griffin0.2%
- Bill Nygren<0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns ALNY · Who owns THC
More on Alnylam Pharmaceuticals
Further comparisons
Alnylam Pharmaceuticals against its closest peers
Tenet Healthcare against its closest peers
Learn
Questions and answers
Which is bigger, Alnylam Pharmaceuticals or Tenet Healthcare?
By market value, Tenet Healthcare is the larger: $22.4B against $21B for Alnylam Pharmaceuticals. By revenue in its latest fiscal year, Tenet Healthcare is the larger: $21.3B against $3.7B for Alnylam Pharmaceuticals.
Which has the higher P/E ratio?
Tenet Healthcare: 8.2, against 7.9 for Alnylam Pharmaceuticals. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Tenet Healthcare: 16.5%, against 13.5% for Alnylam Pharmaceuticals. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Alnylam Pharmaceuticals and Tenet Healthcare?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Alnylam Pharmaceuticals and 3 hold Tenet Healthcare.
Cite this page
Funkfolio, “Alnylam Pharmaceuticals vs Tenet Healthcare”, data as of 18 November 2026. https://funkfolio.com/compare/alny-vs-thc
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.